Ceesay Abraham
Insider CIK 1722140 · CRL Director · PCRX Director · SCPH Chief Operating Officer · CERE President · RAPP Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-10-21 | 2026-10-23 | 2,210 | $29.16 | $64.4K | 450,035 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-10-07 | 2026-10-08 | 1,147 | $30.66 | $35.2K | 452,245 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-10-06 | 2026-10-08 | 3,375 | $32.03 | $108.1K | 453,392 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 215 | $39.86 | $8.6K | 456,810 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 1,952 | $39.05 | $76.2K | 457,025 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 43 | $41.05 | $1.8K | 456,767 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 43 | $41.05 | $1.8K | 456,767 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 215 | $39.86 | $8.6K | 456,810 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 1,952 | $39.05 | $76.2K | 457,025 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 1,069 | $46.01 | $49.2K | 458,977 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 7,141 | $45.56 | $325.3K | 460,046 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 1,069 | $46.01 | $49.2K | 458,977 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 7,141 | $45.55 | $325.3K | 460,046 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 18,921 | $49.57 | $937.9K | 467,187 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 18,921 | $49.57 | $938.0K | 467,187 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-11 | 2026-08-12 | 5,794 | $48.62 | $281.7K | 486,108 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-11 | 2026-08-12 | 19,500 | $48.04 | $936.8K | 491,902 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-11 | 2026-08-12 | 3,664 | $46.90 | $171.8K | 511,402 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-11 | 2026-08-12 | 5,794 | $48.62 | $281.7K | 486,108 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-11 | 2026-08-12 | 19,500 | $48.04 | $936.8K | 491,902 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-11 | 2026-08-12 | 3,664 | $46.90 | $171.8K | 511,402 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-10 | 2026-08-12 | 8,370 | $46.75 | $391.3K | 515,066 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-10 | 2026-08-12 | 14,171 | $45.97 | $651.4K | 523,436 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-10 | 2026-08-12 | 8,370 | $46.75 | $391.3K | 515,066 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-08-10 | 2026-08-12 | 14,171 | $45.97 | $651.5K | 523,436 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-07-27 | 2026-07-29 | 7 | $42.74 | $299 | 537,607 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-07-27 | 2026-07-29 | 2,203 | $42.11 | $92.8K | 537,614 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-07-27 | 2026-07-29 | 7 | $42.73 | $299 | 537,607 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-07-27 | 2026-07-29 | 2,203 | $42.11 | $92.8K | 537,614 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-07-14 | 2026-07-15 | 5,481 | $39.72 | $217.7K | 542,546 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-07-14 | 2026-07-15 | 2,729 | $40.57 | $110.7K | 539,817 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-01 | 7,344 | $39.77 | $292.1K | 548,903 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-01 | 876 | $40.34 | $35.3K | 548,027 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2026-05-08 | 2026-05-11 | 1,438 | $177.62 | $255.4K | 2,384 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-02-18 | 2026-02-19 | 2,281 | $29.80 | $68.0K | 556,247 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-02-18 | 2026-02-19 | 2,983 | $29.04 | $86.6K | 22,829 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-02-18 | 2026-02-19 | 2,100 | $29.80 | $62.6K | 20,729 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-02-18 | 2026-02-19 | 3,552 | $29.05 | $103.2K | 558,528 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 428,000 | — | $0 | 428,000 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-22 | 5,833 | $26.12 | $152.4K | 562,080 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-22 | 5,083 | $26.11 | $132.7K | 25,812 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 2,147 | $28.84 | $61.9K | 33,831 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 600 | $31.04 | $18.6K | 567,913 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 2,441 | $28.84 | $70.4K | 571,305 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 2,421 | $30.04 | $72.7K | 31,410 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 515 | $31.04 | $16.0K | 30,895 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 2,792 | $30.04 | $83.9K | 568,513 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-18 | 2,841 | $25.44 | $72.3K | 35,978 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-18 | 2,777 | $24.92 | $69.2K | 576,802 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-18 | 3,056 | $25.43 | $77.7K | 573,746 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-18 | 2,242 | $24.91 | $55.8K | 38,819 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-16 | 755 | $26.17 | $19.8K | 41,061 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-16 | 4,328 | $25.75 | $111.4K | 41,816 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-16 | 4,647 | $25.72 | $119.5K | 580,765 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-16 | 1,186 | $26.14 | $31.0K | 579,579 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-09-17 | 2025-09-19 | 700 | $27.04 | $18.9K | 46,144 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-09-17 | 2025-09-19 | 34,885 | $26.30 | $917.5K | 46,844 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-09-17 | 2025-09-19 | 1,400 | $26.87 | $37.6K | 585,412 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2025-09-17 | 2025-09-19 | 39,435 | $26.30 | $1.04M | 586,812 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2025-09-04 | 2025-09-08 | 2,354 | $27.19 | $64.0K | 9,039 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 11,279 | — | $0 | 11,279 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2025-06-11 | 2025-06-13 | 6,163 | — | $0 | 11,393 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2025-06-02 | 2025-06-04 | 2,082 | $135.04 | $281.2K | 2,082 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2025-06-02 | 2025-06-04 | 946 | $135.04 | $127.7K | 946 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 428,000 | — | $0 | 428,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2024-06-12 | 2024-06-13 | 12,179 | — | $0 | 12,179 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2024-06-12 | 2024-06-13 | 5,230 | — | $0 | 5,230 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 530,647 | — | $0 | 530,647 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2023-10-06 | 2023-10-11 | 30,967 | — | $0 | 30,967 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 29,083 | — | $0 | 29,083 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 114,445 | — | $0 | 114,445 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-09-08 | 2022-09-12 | 19,210 | — | $0 | 365,009 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-09-08 | 2022-09-12 | 19,210 | $13.17 | $253.0K | 19,210 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-09-08 | 2022-09-12 | 19,210 | $32.50 | $624.3K | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-08-22 | 2022-08-24 | 9,605 | — | $0 | 384,219 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-08-22 | 2022-08-24 | 9,605 | $13.17 | $126.5K | 9,605 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-08-22 | 2022-08-24 | 9,605 | $32.50 | $312.2K | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-08-15 | 2022-08-17 | 9,606 | — | $0 | 393,824 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-08-15 | 2022-08-17 | 9,606 | $13.17 | $126.5K | 9,606 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-08-15 | 2022-08-17 | 9,606 | $34.12 | $327.8K | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-08-08 | 2022-08-09 | 19,211 | — | $0 | 403,430 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-08-08 | 2022-08-09 | 9,605 | $39.50 | $379.4K | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-08-08 | 2022-08-09 | 19,211 | $13.17 | $253.0K | 19,211 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-08-08 | 2022-08-09 | 9,606 | $37.75 | $362.6K | 9,605 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-08-05 | 2022-08-09 | 38,424 | — | $0 | 422,641 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-08-05 | 2022-08-09 | 38,424 | $13.17 | $506.0K | 38,424 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-08-05 | 2022-08-09 | 38,424 | $32.50 | $1.25M | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-02-09 | 2022-02-11 | 120,310 | — | $0 | 120,310 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-06-01 | 2021-06-03 | 461,065 | — | $0 | 461,065 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2018-01-17 | 2018-01-19 | 80,971 | — | $0 | 80,971 | SEC↗ |